Has Wesley Whatley, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,505 in general payments to Wesley Whatley, MD across 88 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wesley Whatley, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wesley Whatley, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wesley Whatley, MD

Otolaryngology · Opelika, ALNPI 1740214626

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.2% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 59.1% of the total.

$3,505in general payments, 2019–2025

Across 88 payments — averaging $39.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$2K
Regeneron Healthcare Solutions, Inc.$386
Optinose US, Inc.$169
Medtronic$167
Stryker$161
Sanofi$147
plus $402 from 11 others

$15,400in research payments, 2019–2025

Across 10 payments — averaging $1540.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Aerin Medical Inc.$15K

What the payments were for

Travel & lodging$3089%
Food & beverage$3,19791%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	29	$2,073
Regeneron Healthcare Solutions, Inc.	17	$386
Optinose US, Inc.	11	$169
Medtronic(2 entities)	2	$167
Stryker	6	$161
Sanofi	5	$147
Intersect ENT, Inc.	2	$139
Aerin Medical Inc.	4	$69
GSK	3	$42
Merck	2	$33
Neurent Medical Limited	1	$24
Eyevance Pharmaceuticals LLC	1	$20
KARL Storz Endoscopy-america	1	$17
Olympus America Inc.	1	$16
Hikma Pharmaceuticals USA	1	$15
Johnson & Johnson	1	$14
Amgen	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire Upper Airway Stimulation System$706
Inspire$573
PROPEL$127

How this compares

$3,505 in reported general payments places this provider in the 75th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama →

Medicare billing

Part B allowed, 2024

$172,583

Medicare patients

470

Services billed

2,672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	322	$11,184
Ipratropium Bromide	114	$4,248
Fluticasone Propionate	256	$3,658
Fluocinolone Acetonide Oil	55	$3,335
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	24	$2,987
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	64	$895
Prednisone	82	$888
Levocetirizine Dihydrochloride	54	$658
Pantoprazole Sodium	102	$558
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	63	$457
Levothyroxine Sodium	43	$428
Ofloxacin	17	$392
Mupirocin	40	$324
Levofloxacin	27	$305
Nystatin	15	$245

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Opelika

William BlytheOpelika$19K
John DavisHoover$251K
William McFeelyHuntsville$70K
Michael SillersBirmingham$53K
Justin TurnerBirmingham$34K
Bradford WoodworthBirmingham$27K
Patrick OwensBirmingham$26K
Kirk WithrowBirmingham$22K
Do-Yeon ChoBirmingham$19K
Andrew FusonBirmingham$18K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →